New drug aims to stop deadly weight loss in colorectal cancer
Symptom relief
Recruiting now
This study tests an experimental drug called NGM120 in people with colorectal cancer who are experiencing cancer cachexia—a condition causing severe weight loss and muscle wasting. The goal is to see if NGM120 can help patients maintain their body weight and improve their quality…
Phase: PHASE2 • Sponsor: NGM Biopharmaceuticals, Inc • Aim: Symptom relief
Last updated Apr 29, 2026 15:05 UTC